Table 2_Galunisertib attenuates pulmonary fibrosis with silicosis in mouse via TGF-β/TRAF6/Beclin1 signaling pathway.xlsx

Table 2_Galunisertib attenuates pulmonary fibrosis with silicosis in mouse via TGF-β/TRAF6/Beclin1 signaling pathway.xlsx

Objective<p>Silicosis is characterized by silicon nodules and diffuse pulmonary fibrosis. To date, no effective therapy has been developed for the treatment of silicosis. This study aimed to investigate the effects of Galunisertib, a TGF-β receptor I kinase inhibitor, on the autophagy-lysosome...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awdur: Rou Li (11575418) (author)
Awduron Eraill: Huimin Kang (435951) (author), Aoxiang Hu (22679153) (author), Guo Chen (182090) (author), Tinghua Yan (18786622) (author), Ting Liu (45625) (author), Shi Chen (120917) (author)
Cyhoeddwyd: 2025
Pynciau:
Pharmacology
Galunisertib
silicosis
TGF-β
autophagy
fibrosis
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg

Eitemau Tebyg